Atherton Lane Advisers’s AbbVie ABBV Stock Holding History

Atherton Lane Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.11M	Buy	18,711 +6	+0%	+$346	0.06%	96
2015 Q3	$1.02M	Sell	18,705 -3,721	-17%	-$242K	0.06%	98
2015 Q2	$1.51M	Buy	22,426 +9,485	+73%	+$619K	0.08%	86
2015 Q1	$758K	Buy	12,941 +276	+2%	+$16.7K	0.04%	141
2014 Q4	$829K	Buy	12,665 +4	+0%	+$252	0.05%	143
2014 Q3	$731K	Sell	12,661 -194	-2%	-$10.8K	0.04%	154
2014 Q2	$726K	Buy	12,855 +405	+3%	+$21.2K	0.04%	155
2014 Q1	$640K	Sell	12,450 -680	-5%	-$34.4K	0.04%	95
2013 Q4	$693K	Sell	13,130 -45	-0.3%	-$2.21K	0.04%	90
2013 Q3	$589K	Buy	13,175 +1,506	+13%	+$66.8K	0.04%	84
2013 Q2	$482K	Buy	+11,669	New	+$510K	0.04%	88

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Atherton Lane Advisers's ABBV Position: Q4 2015 in Review

Atherton Lane Advisers increased its AbbVie (ABBV) stake by 0.03% in Q4 2015, buying an estimated $346 and bringing the position to 18,711 shares worth $1.11M. The position accounts for 0.06% of the portfolio, ranked #96.

Atherton Lane Advisers first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.51M in Q2 2015. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Atherton Lane Advisers held 18,711 shares of AbbVie worth $1.11M as of Q4 2015.
Atherton Lane Advisers bought 6 AbbVie shares in Q4 2015, an estimated $346.
AbbVie made up 0.06% of Atherton Lane Advisers's portfolio in Q4 2015, its #96 holding.
Atherton Lane Advisers first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
Atherton Lane Advisers's AbbVie position peaked at $1.51M in Q2 2015.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.